A deconvolution method to improve automated 3D-analysis of dendritic spines: application to a mouse model of Huntington's disease.

Heck N, Betuing S, Vanhoutte P, Caboche J.

Brain Struct Funct. 2012 Apr;217(2):421-34. doi: 10.1007/s00429-011-0340-y.

Deep brain stimulation of the globus pallidus internal improves symptoms of chorea-acanthocytosis.

Li P, Huang R, Song W, Ji J, Burgunder JM, Wang X, Zhong Q, Kaelin-Lang A, Wang W, Shang HF.

Neurol Sci. 2012 Apr;33(2):269-74. doi: 10.1007/s10072-011-0741-y.

Differential putaminal morphology in Huntington's disease, frontotemporal dementia and Alzheimer's disease.

Looi JC, Rajagopalan P, Walterfang M, Madsen SK, Thompson PM, Macfarlane MD, Ching C, Chua P, Velakoulis D.

Aust N Z J Psychiatry. 2012 Dec;46(12):1145-58. doi: 10.1177/0004867412457224.

Gene expression analysis on a single cell level in Purkinje cells of Huntington's disease transgenic mice.

Euler P, Friedrich B, Ziegler R, Kuhn A, Lindenberg KS, Weiller C, Zucker B.

Neurosci Lett. 2012 May 23;517(1):7-12.

Motor function and dopamine release measurements in transgenic Huntington's disease model rats.

Ortiz AN, Osterhaus GL, Lauderdale K, Mahoney L, Fowler SC, von Hörsten S, Riess O, Johnson MA.

Brain Res. 2012 Apr 23;1450:148-56. doi: 10.1016/j.brainres.2012.02.042.

Making sense out of antisense in Huntington's disease.

Skaper SD.

CNS Neurol Disord Drug Targets. 2012 Sep;11(6):647-8. No abstract available.

Clinical assessment of the effect of tetrabenazine on functional scales in huntington disease: a pilot open label study.

Fekete R, Davidson A, Jankovic J.

Tremor Other Hyperkinet Mov (N Y). 2012;2. pii: tre-02-86-476-4. doi: 10.7916/D8DN43SC.

Multimodal MRI analysis of the corpus callosum reveals white matter differences in presymptomatic and early Huntington's disease.

Di Paola M, Luders E, Cherubini A, Sanchez-Castaneda C, Thompson PM, Toga AW, Caltagirone C, Orobello S, Elifani F, Squitieri F, Sabatini U.

Cereb Cortex. 2012 Dec;22(12):2858-66. doi: 10.1093/cercor/bhr360.

Huntingtin holiday: progress toward an antisense therapy for Huntington's disease."

Lu XH, Yang XW.

Neuron. 2012 Jun 21;74(6):964-6. doi: 10.1016/j.neuron.2012.06.001.

Huntington's disease and the striatal medium spiny neuron: cell-autonomous and non-cell-autonomous mechanisms of disease.

Ehrlich ME.

Neurotherapeutics. 2012 Apr;9(2):270-84. doi: 10.1007/s13311-012-0112-2. Review.

Finding a sirtuin truth in Huntington's disease.

La Spada AR.

Nat Med. 2012 Jan 6;18(1):24-6. doi: 10.1038/nm.2624. No abstract available.

The chorea of McLeod syndrome: progression to hypokinesia.

Miranda M, Jung HH, Danek A, Walker RH.

Mov Disord. 2012 Nov;27(13):1701-2. doi: 10.1002/mds.25224. No abstract available.

Microcirculation response to local cooling in patients with Huntington's disease.

Melik Z, Kobal J, Cankar K, Strucl M.

J Neurol. 2012 May;259(5):921-8. doi: 10.1007/s00415-011-6279-3.

Dysfunction of the ubiquitin ligase Ube3a may be associated with synaptic pathophysiology in a mouse model of Huntington disease.

Maheshwari M, Samanta A, Godavarthi SK, Mukherjee R, Jana NR.

J Biol Chem. 2012 Aug 24;287(35):29949-57. doi: 10.1074/jbc.M112.371724.

SIRT2 ablation has no effect on tubulin acetylation in brain, cholesterol biosynthesis or the progression of Huntington's disease phenotypes in vivo.

Bobrowska A, Donmez G, Weiss A, Guarente L, Bates G.

PLoS One. 2012;7(4):e34805. doi: 10.1371/journal.pone.0034805.